(4-phenyl-piperazino)-acetic acid amide | 197434-83-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: (4-phenyl-piperazino)-acetic acid amide
• 英文别名: (4-Phenyl-piperazino)-essigsaeure-amid；1-Piperazineacetamide, N-phenyl-；2-(4-phenylpiperazin-1-yl)acetamide
• CAS: 197434-83-6
• 化学式: C₁₂H₁₇N₃O
• mdl: MFCD05144689
• 分子量: 219.286
• InChiKey: HOAQKIGCRVMLLG-UHFFFAOYSA-N

物化性质

• 熔点：
  169-170 °C
• 沸点：
  411.0±40.0 °C(Predicted)
• 密度：
  1.147±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.416
• 拓扑面积：
  49.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (4-phenyl-piperazino)-acetic acid amide 在 劳森试剂 作用下， 以 甲苯 为溶剂， 反应 2.0h， 生成 2-(4-Phenylpiperazin-1-yl)ethanethioamide
  参考文献：
  名称：

  Synthesis of arylpiperazines with a terminal naphthothiazole group and their evaluation on 5-HT, DA and a receptor

  摘要：

  The synthesis, affinities for 5-HT1A, 5-HT2, D-1, D-2, alpha(1) and alpha(2) receptors and structure-activity relationships are described for a series of arylpiperazines substituted on the N-4 atom with an omega-(2-naphthothiazole)alkyl chain. The best affinity for 5-HT1A receptors was obtained for 1-(2-methoxyphenyl)piperazine derivatives with IC50 values in the range 3.2-12 nM; however, for all the reported compounds mixed 5-HT1A/D-2/alpha affinities were observed.

  DOI：

  10.1016/s0223-5234(97)88916-7
• 作为产物：
  描述：

  2-(4-苯基哌嗪-1-基)乙腈 在 硫酸 作用下， 生成 (4-phenyl-piperazino)-acetic acid amide
  参考文献：
  名称：

  Derivatives of Piperazine. XXVII. A Modified Strecker Synthesis Utilizing 1-Arylpiperazines¹

  摘要：

  DOI：

  10.1021/ja01606a013

文献信息

• Sulphonamido-substituted bridged bicycloalkyl derivatives
  申请人：——

  公开号：US20040029862A1

  公开（公告）日：2004-02-12

  A class of compounds is disclosed, comprising sulphonamido-substituted bridged bicycloalkyl structures. The compounds are inhibitors of gamma-secretase, and hence are useful in the treatment of and/or prevention of Alzheimer's disease.

  揭示了一类化合物，包括磺胺基取代的桥联双环烷基结构。这些化合物是γ-分泌酶的抑制剂，因此在治疗和/或预防阿尔茨海默病方面是有用的。
• NUCLEOBASE HETEROCYCLIC COMBINATORIALIZATION
  申请人：——

  公开号：US20020009748A1

  公开（公告）日：2002-01-24

  Mixtures of chemical compounds are provided having antibacterial and other utility. The mixtures are formed, preferably in solution phase, from the reaction of a purine or pyrimiding heterocyclic scaffold with a set of related chemical substituients, optionally through employment of a tether moiety. Libraries formed in accordance with the invention have utility per se and are articles of commerce. They can be used to screen for pesticides, drugs and other biologically active compounds.

  提供具有抗菌和其他用途的化合物混合物。这些混合物通常在溶液相中形成，由嘌呤或嘧啶杂环支架与一组相关的化学取代物反应而成，可选地通过使用连接基团。根据本发明形成的文库本身具有实用性并且是商业产品。它们可用于筛选杀虫剂、药物和其他生物活性化合物。
• Isoxazole Derivatives and Use Thereof
  申请人：Cho Jeong Woo

  公开号：US20090131336A1

  公开（公告）日：2009-05-21

  Disclosed herein are isoxazole derivaties and uses thereof. Serving as agonists of Wnt, the isoxazole derivatives activate Wnt/β-catenin signaling and thus can be used in the treatment and prevention of diseases related to the signal transduction. Also, pharmaceutically acceptable salts of the isoxazole derivatives are disclosed.

  本文披露了异噁唑衍生物及其用途。作为Wnt的激动剂，异噁唑衍生物激活Wnt/β-连环蛋白信号传导，因此可用于治疗和预防与信号传导相关的疾病。此外，还披露了异噁唑衍生物的药用盐。
• Nucleobase heterocyclic combinatorialization
  申请人：ISIS Pharmaceuticals, Inc.

  公开号：US20030003505A1

  公开（公告）日：2003-01-02

  Mixtures of chemical compounds are provided having antibacterial and other utility. The mixtures are formed, preferably in solution phase, from the reaction of a purine or pyrimiding heterocyclic scaffold with a set of related chemical substituients, optionally through employment of a tether moiety. Libraries formed in accordance with the invention have utility per se and are articles of commerce. They can be used to screen for pesticides, drugs and other biologically active compounds.

  提供了具有抗菌和其他效用的化合物混合物。这些混合物是通过将嘌呤或嘧啶杂环支架与一组相关的化学取代基反应形成的，最好是在溶液相中，可选择通过使用连接基团来实现。根据本发明形成的文库本身具有效用，并且是商业商品。它们可用于筛选杀虫剂、药物和其他生物活性化合物。
• Sulfamides as gamma-secretase inhibitors
  申请人：——

  公开号：US20040049038A1

  公开（公告）日：2004-03-11

  Novel sulfamides of formula (1) are disclosed. The compounds exert an inhibitory action on the processing of APP by gamma-secretase, and are therefore useful in the treatment or prevention of Alzheimer's disease.

  本发明揭示了式（1）的新型磺胺类化合物。这些化合物对γ-分泌酶加工APP具有抑制作用，因此可用于治疗或预防阿尔茨海默病。